Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
AK1-H5283 | Human | Human Akt1 Protein, His,Strep II Tag |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Capivasertib | AZD-5363 | Approved | Astex Pharmaceuticals Inc, Cancer Research Technology, The Institute Of Cancer Research, London | Truqap | United States | Breast Neoplasms | Astrazeneca Pharmaceuticals Lp | 2023-11-16 | Uterine Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Peritoneal Neoplasms; Metastatic breast cancer; Thyroid Neoplasms; Lung Neoplasms; Prostatic Neoplasms, Castration-Resistant; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Endometrial Neoplasms; Lymphoma; HR-positive breast cancer; Glioma; Uterine Cervical Neoplasms; Melanoma; Squamous Cell Carcinoma of Head and Neck; Hematologic Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Liver Neoplasms; Rectal Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Stomach Neoplasms; Solid tumours; Colonic Neoplasms; Triple Negative Breast Neoplasms; Skin Neoplasms; Carcinoma, Ovarian Epithelial; Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Multiple Myeloma | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Afuresertib | ASB-183; GSK-2110183; GSK-2110183B; GSK-2110183C; GSK-21110183; LAE-002 | Phase 3 Clinical | Glaxosmithkline Plc, Novartis Pharma Ag | Breast Neoplasms; Adenocarcinoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Endometrial Neoplasms; Metastatic breast cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Multiple Myeloma; Triple Negative Breast Neoplasms; Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Solid tumours; Ovarian Neoplasms | Details |
Ipatasertib Dihydrochloride | RG-7440; GCD-0068; GDC-0068; RO-5532961 | Phase 3 Clinical | Array Biopharma, F. Hoffmann-La Roche Ltd | Paranasal Sinus Neoplasms; Hepatic Insufficiency; Urogenital Neoplasms; Neoplasms, Unknown Primary; Endometrial Neoplasms; Carcinoma, Squamous Cell; Lip Neoplasms; Laryngeal Neoplasms; Mouth Neoplasms; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Paranasal Sinus Diseases; Uterine Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid; Adenocarcinoma; Glioblastoma; Solid tumours; Neoplasm, Residual; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Cystadenocarcinoma, Serous; Triple Negative Breast Neoplasms; Neoplasms; Ovarian Neoplasms; Hypopharyngeal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Cholangiocarcinoma; Genital Neoplasms, Female; Oropharyngeal Neoplasms | Details |
TIC-10 | ONC201 - Oncoceutics; ONC201/TIC10; NSC-350625; TIC-10; ONC-201 | Phase 3 Clinical | Oncoceutics Inc | Diffuse Intrinsic Pontine Glioma; Central Nervous System Lymphoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Meningioma; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Adenomatous Polyps; Endometrial Neoplasms; Glioma; Gliosarcoma; Colorectal Neoplasms; Adenomatous Polyposis Coli; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Mantle-Cell; Breast Neoplasms; Multiple Myeloma; Neoplasms; Myelodysplastic Syndromes; Triple Negative Breast Neoplasms; Thalamic Diseases; Glioblastoma; Diffuse midline glioma; Solid tumours | Details |
Triciribine Phosphate | NSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200 | Phase 2 Clinical | National Cancer Institute | Ovarian Neoplasms; Hematologic Neoplasms; Leukemia; Neoplasms; Breast Neoplasms | Details |
Miransertib | MK-7075; ARQ-092 | Phase 2 Clinical | Arqule Inc | Proteus Infections; Solid tumours; Ovarian Neoplasms; Neoplasms; PIK3CA-Related Overgrowth Spectrum; Proteus Syndrome; Lymphoma; Endometrial Neoplasms | Details |
Iopofosine I-131 | CLR-131; NM404; (131)I-CLR1404; 131I-NM-404; HOT; CLR1404 I-131; I-131-CLR1404; (131)I-NM 404 | Phase 2 Clinical | University Of Michigan | Neuroblastoma; Central Nervous System Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Glioma; Waldenstrom Macroglobulinemia; Diffuse Intrinsic Pontine Glioma; Sarcoma, Ewing; Brain Neoplasms; Lymphoma, B-Cell, Marginal Zone; Osteosarcoma; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Rhabdomyosarcoma; Solid tumours; Head and Neck Neoplasms | Details |
Uprosertib/Trametinib Dimethyl Sulfoxide | Phase 2 Clinical | Novartis Pharma Ag | Leukemia, Myeloid, Acute; Endometrial Neoplasms; Uterine Cervical Neoplasms | Details | |
TAS-117 | TAS-117 | Phase 2 Clinical | Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd | Solid tumours | Details |
Selumetinib sulfate/MK-2206 | Phase 2 Clinical | Astrazeneca Plc, Merck & Co Inc | Rectal Neoplasms; Triple Negative Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma | Details | |
Uprosertib | GSK-795; GSK-2141795; GSK-2141795C; UPB-795 | Phase 2 Clinical | Glaxosmithkline Plc, Novartis Pharma Ag, National Cancer Institute | Solid tumours; Hematologic Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Multiple Myeloma; Breast Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Uterine Neoplasms; Endometrial Neoplasms; Uterine Cervical Neoplasms; Melanoma; Adenocarcinoma | Details |
RX-0301 | RX-0301; WGI-0301; RX-0201 nanoliposomal; RX-0201 Nano; RX-0201-N; RX-0201改良型; HC0301 | Phase 2 Clinical | Rexahn Pharmaceuticals Inc | Liver Neoplasms; Solid tumours; Carcinoma, Hepatocellular | Details |
MK-2206 | NSC-749607; BIND-2206; MK2206; MK-2206 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Leukemia, Myelomonocytic, Juvenile; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Neoplasms, Gonadal Tissue; Gallbladder Neoplasms; Burkitt Lymphoma; Endometrial Neoplasms; Lymphoma, T-Cell; Waldenstrom Macroglobulinemia; Lymphoma; Leukemia, Monocytic, Acute; Glioma; Peritoneal Neoplasms; Adenocarcinoma, Bronchiolo-Alveolar; Colorectal Neoplasms; Sezary Syndrome; Leukemia, Myeloid, Chronic-Phase; Bile Duct Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lymphoproliferative Disorders; Cholangiocarcinoma; Carcinoma, Adenosquamous; Adenocarcinoma; Breast Neoplasms, Male; Mycosis Fungoides; Melanoma; Leukemia, Prolymphocytic; Leukemia, T-Cell; Carcinoma, Non-Small-Cell Lung; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Central Nervous System Lymphoma; Carcinoma, Hepatocellular; Breast Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, Large-Cell, Anaplastic; Adenocarcinoma, Mucinous; Thymoma; Lung Neoplasms; Leukemia, Myeloid, Acute; Fallopian Tube Neop | Details |
NTQ-1062 | NTQ-1062; NTQ1062 | Phase 2 Clinical | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Solid tumours; Breast Neoplasms; HR-positive breast cancer | Details |
HZB-0071 | HZB-0071 | Phase 1 Clinical | Wuxi Apptec Co Ltd, Heilongjiang Zbd Pharmaceutical Co Ltd | Neoplasms | Details |
Rupitasertib | DIACC3010; M-2698; MSC-2363318A; DIACC-3010 | Phase 1 Clinical | Emd Serono Inc | Solid tumours; Stomach Neoplasms; Glioblastoma; Breast Neoplasms | Details |
Honokiol | HU-002; JRF-101 | Phase 1 Clinical | Anacor Pharmaceuticals Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Gingival Diseases; Carcinoma, Non-Small-Cell Lung | Details |
CMX-2043 | LIP-EA; CMX-2043; R-LIP-EA-OH | Phase 1 Clinical | Ischemix Llc | Brain Injuries, Traumatic; Angina, Unstable; Coronary Artery Disease | Details |
Hu-7691 | Hu-7691 | Phase 1 Clinical | Zhejiang University | Solid tumours; Neoplasms | Details |
Oxysterols (Intsel Chimos) | Clinical | Centre National De La Recherche Scientifique (Cnrs) | Glioma | Details |
This web search service is supported by Google Inc.